HUMAN METAPNEUMOVIRUS

Clinical trials for HUMAN METAPNEUMOVIRUS explained in plain language.

Never miss a new study

Get alerted when new HUMAN METAPNEUMOVIRUS trials appear

Sign up with your email to follow new studies for HUMAN METAPNEUMOVIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

New Two-in-One shot tested to protect seniors from common respiratory viruses

⭐️ VACCINE ⭐️ Completed

This study tested a new vaccine designed to protect against two common respiratory viruses, RSV and human metapneumovirus (hMPV), in adults aged 60 and older. Researchers gave 646 healthy participants a single shot to check for safety and to see if it triggered a strong immune re…

Matched conditions: HUMAN METAPNEUMOVIRUS

Phase: PHASE1, PHASE2 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️

Last updated Mar 30, 2026 14:33 UTC

HUMAN METAPNEUMOVIRUS

Get alerted when new HUMAN METAPNEUMOVIRUS trials appear

New Two-in-One shot tested to protect seniors from common respiratory viruses